Emergent Biosolutions, Inc.

Historical 13F Holders

Symbol
EBS
CUSIP
29089Q105
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 29089Q105 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 9.0% 7/28/2026
Event 6/30/2026
American Century Investment Management, Inc. 13G
5.4% 8/14/2026
Event 6/30/2026
Dimensional Fund Advisors LP 13G 5.3% 4/9/2026
Event 3/31/2026
State Street Corp 13G 5.1% 2/9/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Vanguard Capital Management LLC 13G/A 4.9% 7/31/2026
Event 6/30/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 9 20.7 k $140 k
2026 Q2 202 44.6 M $375 M
2026 Q1 197 43.4 M $361 M
2025 Q4 193 43.5 M $538 M
2025 Q3 184 41.7 M $353 M
2025 Q2 177 40.1 M $244 M
2025 Q1 169 36.2 M $176 M
2024 Q4 168 34.7 M $332 M
2024 Q3 154 31.7 M $264 M
2024 Q2 150 32.3 M $220 M
2024 Q1 133 38.8 M $98.4 M
2023 Q4 147 42.9 M $103 M
2023 Q3 171 41.3 M $141 M
2023 Q2 194 45.7 M $337 M
2023 Q1 201 45.0 M $466 M
2022 Q4 209 52.1 M $615 M
2022 Q3 225 40.7 M $855 M
2022 Q2 245 41.2 M $1.28 B
2022 Q1 269 42.1 M $1.73 B
2021 Q4 269 42.9 M $1.87 B
2021 Q3 289 44.5 M $2.23 B
2021 Q2 305 44.8 M $2.82 B
2021 Q1 356 44.6 M $4.14 B
2020 Q4 373 45.9 M $4.11 B
2020 Q3 372 43.2 M $4.47 B
2020 Q2 311 53.8 M $4.21 B
2020 Q1 274 45.4 M $2.62 B
2019 Q4 245 45.6 M $2.46 B
2019 Q3 251 45.0 M $2.35 B
2019 Q2 239 46.0 M $2.22 B
2019 Q1 283 45.3 M $2.29 B
2018 Q4 309 44.2 M $2.62 B
2018 Q3 291 43.8 M $2.89 B
2018 Q2 271 42.8 M $2.16 B
2018 Q1 277 42.6 M $2.23 B
2017 Q4 243 40.4 M $1.88 B
2017 Q3 201 37.1 M $1.50 B
2017 Q2 185 35.6 M $1.20 B
2017 Q1 180 35.7 M $1.04 B
2016 Q4 218 35.9 M $1.18 B
2016 Q3 210 35.9 M $1.13 B
2016 Q2 237 36.2 M $1.02 B
2016 Q1 224 33.7 M $1.23 B
2015 Q4 210 32.8 M $1.31 B
2015 Q3 204 32.9 M $952 M
2015 Q2 185 31.0 M $1.02 B
2015 Q1 176 30.4 M $874 M
2014 Q4 172 30.0 M $816 M
2014 Q3 168 29.9 M $638 M
2014 Q2 165 34.6 M $776 M
2014 Q1 170 28.8 M $729 M